Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series

Clinical outcomes of post‐renal transplant patients with COVID‐19 infection in the ICU: A single‐center case series

Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19...

Full description

Bibliographic Details
Main Authors: Nissar Shaikh, Mohamad Y. Khatib, Mohammad A. Alwraidat, Dore C. Ananthegowda, Muftah Othman, Asra Aroos, Sagar B. Jujjavarapu, Saptarshi Banerjee, Zishan Nasir, Ahmed S. Mohamed, Moustafa S. Elshafei, Muna A. Almaslamani, Abdulqadir J. Nashwan
Format: Article
Language:English
Published: Wiley 2021-07-01
Series:Clinical Case Reports
Subjects:
acute kidney injury
COVID‐19 infection
end‐stage renal disease
hypertension
immunosuppression
renal transplant
Online Access:https://doi.org/10.1002/ccr3.4513
Description
Summary:Abstract Most of the post‐renal transplant patients are taking immunosuppressive medications, including calcineurin inhibitors, anti‐proliferative agents, and steroids. This case series highlights the clinical characteristics and outcomes of eight post‐renal transplant patients with severe COVID‐19 infection admitted to the intensive care unit.
ISSN:2050-0904

Similar Items